PSP001 - A First-in-disease human PEGIFN-λ Chimera

May 24th,2021 FIH Phase 1;
Date:2023-04-06 15:16:49 | Visits：


 
 Prev:Prosit Sole Biotechnology Initiates First-In-Human Clinical Trial of Novel Interferon Lambda Chimera in US
 Next:
Contact

Beijing Headquarter:

Add: A302 No.5 Kaituo Road, Haidian District, Beijing, China, 100085


Tel: +86-10-62975234

Manufacturing Facility & Laboratory:

Building No. 3, Peptide Valley, GuAn, Hebei, China

US Clinical Center:

Seattle, WA, USA

Copyright 2021 prositsole All Rights Reserved.  备案号：京ICP备19006758号-2